1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics, June 2017 (p20)

Pharmaceutical Analysis & Statistics, June 2017 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

571-600 of about 21000 reports

Purchase Reports From Reputable Market Research Publishers

Human Papillomavirus Minor Capsid Protein L2 (L2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Human Papillomavirus Minor Capsid Protein L2 (L2) - Pipeline Review, H1 2017 Summary According to the recently published report 'Human Papillomavirus Minor Capsid Protein L2 (L2) - Pipeline Review, H1 ...

  • Industries : Therapy
  • Countries : World, United States

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2017 Summary According to the recently published report 'Protein Phosphatase 2A - Pipeline Review, H1 2017'; Protein Phosphatase 2A (PP2A ...

  • Industries : Therapy, Pathology, Cancer
  • Countries : United States

Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) - Pipeline Review, H1 2017 Summary Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src ...

  • Industries : Pathology, Therapy, Cancer
  • Countries : World, United States

cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H1 2017 Summary cAMP and cAMP ...

  • Industries : Pharmaceutical
  • Countries : World

Mitogen Activated Protein Kinase Kinase Kinase 7 (Transforming Growth Factor Beta Activated Kinase 1 or MAP3K7 or EC 2.7.11.25) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Mitogen Activated Protein Kinase Kinase Kinase 7 (Transforming Growth Factor Beta Activated Kinase 1 or MAP3K7 or EC 2.7.11.25) - Pipeline Review, H1 2017 Summary According to the recently published report ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are ...

  • Industries : Pathology, Cancer
  • Countries : World, United States

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017 Summary According to the recently published report 'Integrin Beta ...

  • Industries : Therapy, Health Services, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States

Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Pipeline Review, H1 2017 Summary According to the recently published report ...

  • Industries : Pathology, Therapy, Cancer
  • Countries : World

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H1 2017 Summary According to the recently published report 'TGF Beta Receptor Type ...

  • Countries : World

Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Pipeline Review, H1 2017 Summary According to the recently published report 'Bromodomain Containing Protein 3 - Pipeline Review, H1 2017'; ...

  • Industries : Cancer, Pathology
  • Countries : United States, Europe

Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H1 2017 Summary Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Histone deacetylase 4 (HDAC4) ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States

Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H1 2017 Summary According to the recently published report ...

  • Industries : Pathology, Therapy, Cancer, Mental Health
  • Countries : United States, Europe, France, World

Partnerships, Licensing, Investments and M&A Deals and Trends for 2016 in Pharmaceuticals

  • $ 3500
  • Industry report
  • June 2017
  • by GlobalData

Partnerships, Licensing, Investments and M&A Deals and Trends for 2016 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for 2016 in Pharmaceuticals" ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : World

Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H1 2017 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target constitutes ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H1 2017 Summary Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) pipeline Target constitutes close ...

  • Industries : Therapy, Pathology, Cancer, Biological Therapy, Oncology
  • Countries : United States

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H1 2017 Summary Nitric ...

  • Industries : Therapy
  • Countries : New Caledonia

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017 Summary Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World

Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H1 2017 Summary Transforming Growth Factor Beta 1 (TGFB1) - Transforming growth factor beta 1 (TGF-?1) is a polypeptide member of the transforming ...

  • Industries : Therapy, Pathology, Chronic Disease, Pharmaceutical
  • Countries : United States

RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H1 2017 Summary RAC Alpha Serine/Threonine ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States

Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Pipeline Review, H1 2017 Summary Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) pipeline Target ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : China, Japan

Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or PARP2 or EC 2.4.2.30) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or PARP2 or EC 2.4.2.30) - Pipeline Review, H1 2017 Summary ...

  • Industries : Cancer, Therapy, Pathology, Oncology
  • Countries : United States

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H1 2017 Summary According to the recently published report 'Cyclin Dependent Kinase 4 - Pipeline ...

  • Industries : Therapy, Cancer, Oncology, Pathology
  • Countries : United States

Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21) - Pipeline Review, H1 2017 Summary Serine/Threonine Protein Kinase PLK1 (Polo Like ...

  • Industries : Cancer, Pathology
  • Countries : United States

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2017 Summary According to the recently published report 'Islet Amyloid Polypeptide ...

  • Industries : Chronic Disease, Therapy, Pathology, Pharmaceutical
  • Countries : World, United States

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2017 Summary According to the recently published ...

  • Industries : Cancer, Pathology, Biological Therapy, Therapy
  • Countries : United States, World

Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) - Pipeline Review, H1 2017 Summary Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) pipeline Target constitutes close ...

  • Industries : Therapy, Pathology, Health Services
  • Countries : United States

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H1 2017 Summary According to the recently published report 'SerineThreonine Protein Kinase Pim 3 - Pipeline ...

  • Industries : Cancer, Pathology, Pharmaceutical
  • Countries : World

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H1 2017 Summary Human Papillomavirus Protein E6 (E6) - The Human Papillomavirus (HPV) E6 protein is one of oncoproteins encoded by the virus. It ...

  • Industries : Pathology, Therapy, Cancer, Healthcare, Pharmaceutical
  • Countries : United States, World

RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - Pipeline Review, H1 2017 Summary According to the recently published report ...

  • Industries : Cancer, Pathology
  • Countries : United States, World

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H1 2017 Summary Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumo ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.